Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,290,104 papers from all fields of science
Search
Sign In
Create Free Account
monatepil
Known as:
11-((4-(4-(4-fluorophenyl)-1-piperazinyl)butyryl)amino)-6,11-dihydrodibenzo(b,e)thiepin maleate
, (+/-)-N-(6,11-Dihydrodibenzo(B,E)Thiepin-11-yl)-4-(P-Fluorophenyl)-1-Piperazinebutyramide
, 1-Piperazinebutanamide, N-(6,11-dihydrodibenzo(b,e)thiepin-11-yl)-4-(4-fluorophenyl)-, (Z)-2-butenedioate (1:1)
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Narrower (2)
AJ 2615
monatepil maleate
Broader (5)
Adrenergic alpha-Antagonists
Antihypertensive Agents
Calcium Channel Blockers
Dibenzothiepins
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Effect of monatepil, a calcium channel blocker in ocular hypertensive rabbits
S. Panchal
,
A. Mehta
,
D. Santani
2017
Corpus ID: 78438496
2013
2013
Synthesis and characterization
C. Stecoza
,
Corina Ilie
,
M. Cǎproiu
2013
Corpus ID: 264043535
http://www.revistadechimie.ro 529 Dibenzothiepines are well-known especially for their antidepressant activity (e.g. Dosulepin…
Expand
1997
1997
Effects of Monatepil, a Novel Calcium Antagonist with α1-Adrenergic Blocking Activity, on the Low-Density Lipoprotein Receptor in Human Skin Fibroblasts
A. Matsunaga
,
Tadao Inoue
,
+4 authors
K. Arakawa
Cardiovascular Drugs and Therapy
1997
Corpus ID: 24868065
To investigate the mechanisms of the hypolipidemic effect ofmonatepil, a new class of calcium antagonists withα1-adrenergic…
Expand
1995
1995
Relative Contribution of α1-Adrenoceptor Blocking Activity to the Hypotensive Effect of the Novel Calcium Antagonist Monatepil
T. Sugimoto
,
K. Hosoki
,
T. Karasawa
Journal of Cardiovascular Pharmacology
1995
Corpus ID: 1548014
Summary: Monatepil, a novel calcium antagonist, has α1-adrenoceptor blocking activity; in the present study, we examined the…
Expand
Review
1995
Review
1995
Newer antihypertensive drugs.
J. Gregoire
,
S. Sheps
Current Opinion in Cardiology
1995
Corpus ID: 19367456
We review three new classes of antihypertensive drugs: imidazolines, monatepil, and neutral endopeptidase inhibitors…
Expand
1994
1994
The efficacy of monatepil, a new calcium antagonist, in the treatment of essential hypertension.
M. Ishii
,
O. Iimura
,
+7 authors
M. Kuramochi
American Journal of Hypertension
1994
Corpus ID: 27044824
A multicenter, open-label trial in Japan examined the efficacy, safety, and optimal dose of monatepil (AJ-2615) as monotherapy…
Expand
1994
1994
Preventive effect of monatepil on thromboxane A2 agonist-induced myocardial ischemia in rats.
T. Yamamoto
,
K. Hosoki
,
C. Kikuta
,
T. Karasawa
Arzneimittel-Forschung
1994
Corpus ID: 23317782
Antianginal effects of monatepil ([(+-)-N-(6,11-dihydrodibenzo[b,e]thiepin-11-yl)-4-(4-fluor ophenyl)-1-piperazinebutanamide…
Expand
Review
1994
Review
1994
New therapeutic trends in calcium antagonism. Are they meaningful?
W. Nayler
American Journal of Hypertension
1994
Corpus ID: 20239218
Recent advances in the field of calcium antagonism include the development of long-acting calcium antagonists, some of which have…
Expand
1993
1993
PREVENTIVE EFFECT OF A NEW CALCIUM ANTAGONIST, MONATEPIL, ON DRUG‐INDUCED ISCHAEMIC ELECTROCARDIOGRAPHIC CHANGES IN RATS
Taku Yamamoto
,
K. Nakatsuji
,
K. Hosoki
,
T. Karasawa
Clinical and Experimental Pharmacology and…
1993
Corpus ID: 24136496
1. The preventive effects of monatepil, a new calcium antagonist with α1‐adrenoceptor blocking activity, on ischaemic…
Expand
1993
1993
Anti-arrhythmic effects of a new calcium antagonist, monatepil, AJ-2615, in experimental arrhythmic models [corrected].
T. Yamamoto
,
K. Hosoki
,
T. Karasawa
Clinical and Experimental Pharmacology and…
1993
Corpus ID: 39220681
1. To characterize the anti-arrhythmic properties of a new calcium antagonist, monatepil [corrected], AJ-2615, the preventive…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE